Corneal dystrophy-perceptive deafness syndrome

Corneal dystrophy-perceptive deafness syndrome
Corneal dystrophy-perceptive deafness syndrome is a rare genetic disorder characterized by the presence of corneal dystrophy and sensorineural hearing loss. This syndrome affects the cornea of the eye and the inner ear, leading to visual and auditory impairments.
Signs and Symptoms
Individuals with corneal dystrophy-perceptive deafness syndrome typically present with:
- Progressive corneal dystrophy, which can lead to corneal opacification and vision loss.
- Sensorineural hearing loss, which is a type of hearing loss resulting from damage to the cochlea or the auditory nerve.
Genetics
The syndrome is believed to be inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the defective gene, one from each parent, to be affected. The specific gene or genes involved in this syndrome have not been definitively identified.
Diagnosis
Diagnosis of corneal dystrophy-perceptive deafness syndrome typically involves:
- Ophthalmologic examination to assess the extent of corneal dystrophy.
- Audiometric testing to evaluate the degree of hearing loss.
- Genetic testing may be conducted to identify mutations in genes known to be associated with similar syndromes.
Treatment
There is currently no cure for corneal dystrophy-perceptive deafness syndrome. Treatment is generally symptomatic and supportive, including:
- Use of hearing aids or cochlear implants to manage hearing loss.
- Corneal transplantation may be considered in severe cases of corneal dystrophy.
Prognosis
The prognosis for individuals with corneal dystrophy-perceptive deafness syndrome varies depending on the severity of the symptoms. Early intervention and supportive treatments can help manage the symptoms and improve the quality of life.
See Also
References
External Links
-

This article is a genetic disorder stub. You can help WikiMD by expanding it!
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
